Paladin Labs News and Activities

Paladin Labs is owned by Knight Therapeutics. Knight Therapeutics has a direct presence in 2 countries.

They are in:

• Biotechnology50%
• Pharmaceuticals50%

Acquisition, funding and merger involving Knight Therapeutics.

• Knight Therapeutics has announced the acquisition of Paladin Labs  (posted on March 12 2025).

View the org chart displaying its 3 main executives

Most searched biographies at Paladin Labs

• Livio Di Francesco, Vice President and General Manager
• Daniel Vas, Executive Director, Finance
• Isabelle Trempe, Vice President, Business Development

Popular executive movements at Knight Therapeutics

• Christine Poulin, General Manager, North America, has left the company  (posted on January 14 2026).

Create your alert
to follow the executive moves at Paladin Labs.

Knight Therapeutics has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Richard Saynor - Chief Executive Officer at Sandoz
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott

Learn more about the Pharmaceuticals industry

Press releases by Paladin Labs

Social media about Paladin Labs

• Paladin Labs on Wikipedia, Google News & Yahoo Finance
• Paladin Labs on LinkedIn, X (Twitter) & YouTube